Sarnia Institute of Clinical Research

Sarnia, Ontario N7T4X3

0 studies enrolling now · 9 studies all time

What they study most

Cardiovascular Disease, Diabetes Type 2, Diabetes, Type 1, Diabetes, Type 2, Irritable Bowel Syndrome, Meningococcal Infections, Type 1 Diabetes, Type 2 Diabetes

Studies at this site

• Cardiovascular Inflammation Reduction Trial — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children — Completed
• A 2-Month Safety Follow-Up Trial — Completed
• Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up — Completed
• Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes — Completed
• A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females — Status unconfirmed
• 8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS — Completed